Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 24.1B | 25.5B | 23.2B | 23.4B |
Cost of revenue | 9.6B | 11.3B | 9.2B | 9.7B |
Gross profit | 14.5B | 14.2B | 14.0B | 13.7B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 3.9B | -1.1B | 3.6B | 3.5B |
Operating income | 6.2B | 7.8B | 6.4B | 6.2B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 30M | 10M | 0 | 10M |
Other income expense | — | — | — | — |
Pretax income | 7.3B | 8.6B | 7.3B | 7.2B |
Tax provision | 1.9B | 2.0B | 1.4B | 2.1B |
Net income | 5.5B | 6.6B | 5.9B | 5.1B |
Basic EPS | 20.5 | — | 22.2 | 19.2 |
Diluted EPS | 20.5 | — | 22.2 | 19.2 |
Basic average shares | 266.0M | — | 265.3M | 265.6M |
Diluted average shares | 266.0M | — | 265.3M | 265.6M |
EBITDA | 8.5B | 9.7B | 8.3B | 8.2B |
Net income from continuing op. | — | — | — | — |
Minority interests | 0 | 0 | 0 | 0 |
Preferred stock dividends | 0 | 0 | 0 | 0 |